Ihr Browser ist nicht auf dem aktuellen Stand.

Mit einem aktualisierten Browser können Sie die Website von Medtronic besser nutzen. Browser jetzt aktualisieren.

×

Skip to main content

Why parathyroid tissue detection?     Hypoparathyroidism challenges     KOL Voices

 

Protect with confidence1 your patient's healthy parathyroid tissue — and their quality of life2

PTeye™ parathyroid detection system

The PTeye™ parathyroid detection system is an intra-operative probe-based technology to aid you in confirming suspected parathyroid tissue during thyroid and parathyroid surgery.3

Up to 22% of thyroid surgeries result in incidental parathyroid removal.4 This puts patients at risk for hypoparathyroidism — a condition associated with a number of short- and long-term complications.2,5-9

Download product brochure
PTeye parathyroid detection system


up to

96%
accuracy3

 

Real-time confirmation

Add to your visual identification of the parathyroid gland with PTeye™ parathyroid detection system, providing real-time confirmation with up to 96% accuracy.3

PTeye™ parathyroid system is based on an intraoperative technique that uses near-infared (NIR) autoflourescence for in vivo, real-time confirmation of visually suspected parathyroid tissue.3

PTeye parathyroid detection system

Identify with confidence

 

88.9%

Confirming parathyroid gland tissue in 88.9% (24/27) of the cases1

When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and confirming PG tissue in 88.9% (24/27) of cases¹

 

7.4%

Prevented surgeon error in
7.4% (2/27) of times1

When identified with medium confidence, PTeye™ was highly beneficial for further improving the surgeon's confidence and preventing surgeon error in 7.4% (2/27).¹


Surgeons reported improved confidence in identifying parathyroid glands by using PTeye™1

In a study, surgeons reported that using the PTeye™ system improved confidence in identifying the parathyroid gland, regardless of the experience.¹

KOL voices

Discover what your peers say about the importance of the parathyroid detection and the Medtronic PTeye™ parathyroid detection system.

Watch video
Dr. Solorzano

Carmen C. Solórzano, M.D., FACS

Get in contact and discover the PTeye™ parathyroid detection system

Learn more about the PTeye™ system live with your Medtronic representative during a product demonstration. By submitting the form, we will get a notification to reach out to you. We are looking forward to introducing this new technology to you.

*Pflichtfeld

Ihre Informationen werden im Einklang mit unserer Datenschutzerklärung verarbeitet und geschützt.

Wenn Sie oben für die Marketing-E-Mails „Nein“ wählen, hat dies keine Auswirkungen auf Ihre sonstige E-Mail-Auswahl. Sie bekommen trotzdem E-Mails der Vertretung von Medtronic, wenn dies ausgewählt ist.  Ihre personenbezogenen Daten werden verwendet, um Ihre Beziehung zu Medtronic zu verwalten und, falls Sie zustimmen, Ihnen auf der Grundlage Ihrer Benutzereinstellungen per E-Mail Informationen über relevante Neuerungen zukommen zu lassen. Sie können den Erhalt solcher E-Mails jederzeit abbestellen, indem Sie auf den Abmeldelink in der entsprechenden E-Mail klicken. Medtronic kann Pixel und andere Technologien in E-Mails verwenden, um Statistiken über das Öffnen von E-Mails und Klicks zu sammeln, um unsere Kommunikation zu verbessern und Ihnen relevante Inhalte zu bieten. Weitere Informationen finden Sie in den Medtronic-Datenschutzrichtlinien.

Sie können Ihre Einstellungen jederzeit ändern oder Ihre personenbezogenen Daten aktualisieren, indem Sie das Präferenzzentrum besuchen.

Präferenzzentrum besuchen

1

Kiernan CM, Thomas G, Baregamian N, Solόrzano CC. Initial clinical experiences using the intraoperative probe-based parathyroid autofluorescence identification system - PTeye™ during thyroid and parathyroid procedures. J Surg Oncol. 2021;124:271–281.

2

Siggelkow, H, Clarke, BL, Germak, J, et al. Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13-country patient and caregiver survey. Clin Endocrinol (Oxy), 2020; 92: 159–168. doi: 10.1111/cen.14128. Epub 2019 Dec 11. PMID: 31721256; PMCID: PMC7027891.

3

PTeye IFU M012700C001

4

Applewhite M. et al Incidence, Risk Factors, and Clinical Outcomes of Incidental Parathyroidectomy During Thyroid Surgery, Ann Surg Oncol 2016 Dec; 23(13):4310–4315. doi: 10.1245/s10434-016-5439-1. Epub 2016 Aug 19. PMID: 27541813.

5

Büttner M, Singer S, Taylor K. Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review. Endocrine. 2024 Apr 5. doi: 10.1007/s12020-024-03807-2. Epub ahead of print. PMID: 38578400.

6

Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study. J Bone Miner Res. 2013 Nov;28(11):2277–85. doi: 10.1002/jbmr.1979. PMID: 23661265.

7

Underbjerg L, Sikjaer T, Mosekilde L, Rejnmark L. Postsurgical hypoparathyroidism--risk of fractures, psychiatric diseases, cancer, cataract, and infections. J Bone Miner Res. 2014 Nov;29(11):2504–10. doi: 10.1002/jbmr.2273. PMID: 24806578

8

Underbjerg L, Sikjaer T, Rejnmark L. Long-Term Complications in Patients With Hypoparathyroidism Evaluated by Biochemical Findings: A Case-Control Study. J Bone Miner Res. 2018 May;33(5):822–831. doi: 10.1002/jbmr.3368. Epub 2018 Feb 14. PMID: 29281760.

9

Gosmanova EO, Chen K, Ketteler M, et al. Risk of Cardiovascular Conditions in Patients with Chronic Hypoparathyroidism: A Retrospective Cohort Study. Adv Ther. 2021 Aug;38(8):4246–4257. doi: 10.1007/s12325-021-01787-7. Epub 2021 Jun 24. PMID: 34165700; PMCID: PMC8342323.

See the device manual for detailed information regarding the instructions for use, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.de.